Iron overload may still occur in transfusion-independent patients with β-thalassemia intermedia due to increased intestinal iron absorption. In this study, we evaluated the association between iron overload, using a liver iron concentration threshold of therapeutic significance (≥ 5 mg/g), and morbidity in 168 chelation naive patients with β-thalassemia intermedia. We demonstrated that patients with a liver iron concentration ≥ 5 mg/g have a significantly higher prevalence of several serious vascular and endocrine/bone morbidities than do patients with < 5 mg/g, and we established absolute morbidity risk values differentiating both groups. We also demonstrated that the association between iron overload and morbidity in such patients is independent of the effects of advancing age and disease severity. These findings suggest that treating iron burden in β-thalassemia intermedia may be associated with reduction in serious morbidity risk

Evaluation of the 5mg/g liver iron concentration threshold and its association with morbidity in patients with β-thalassemia intermedia / K.M. Musallam, M.D. Cappellini, A.T. Taher. - In: BLOOD CELLS, MOLECULES, & DISEASES. - ISSN 1079-9796. - 51:1(2013 Jun), pp. 35-38.

Evaluation of the 5mg/g liver iron concentration threshold and its association with morbidity in patients with β-thalassemia intermedia

M.D. Cappellini
Secondo
;
2013

Abstract

Iron overload may still occur in transfusion-independent patients with β-thalassemia intermedia due to increased intestinal iron absorption. In this study, we evaluated the association between iron overload, using a liver iron concentration threshold of therapeutic significance (≥ 5 mg/g), and morbidity in 168 chelation naive patients with β-thalassemia intermedia. We demonstrated that patients with a liver iron concentration ≥ 5 mg/g have a significantly higher prevalence of several serious vascular and endocrine/bone morbidities than do patients with < 5 mg/g, and we established absolute morbidity risk values differentiating both groups. We also demonstrated that the association between iron overload and morbidity in such patients is independent of the effects of advancing age and disease severity. These findings suggest that treating iron burden in β-thalassemia intermedia may be associated with reduction in serious morbidity risk
Iron overload; Liver iron concentration; Morbidity; Thalassemia intermedia
Settore MED/09 - Medicina Interna
giu-2013
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1079979613000168-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 365.41 kB
Formato Adobe PDF
365.41 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/219289
Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 46
  • ???jsp.display-item.citation.isi??? 46
social impact